Hospice Length of Stay: National Data, Trends, and Clinical Implications

Key Statistics (NHPCO, 2022–2023 Data)

  • Median length of stay (LOS): 17 days (half of patients die within 17 days of enrollment).
  • Mean (average) LOS: 74 days — skewed by long-stay outliers.
  • Percentage with LOS ≤7 days: ~30% (late referrals).
  • Percentage with LOS >180 days: ~10–12% (live discharges, disease trajectory).

LOS by Diagnosis

Trends Over Time

  • Median LOS stable at 17–18 days since 2010 (despite earlier referral efforts).
  • Mean LOS increased from ~65 to 74 days (more long-stay non-cancer patients).
  • Live discharge rate: 15–17% (condition improvement, revocation, transfer).

Clinical and Policy Implications

  • Late enrollment (≤7 days): Misses full hospice benefit (symptom control, psychosocial support, bereavement). Associated with higher ICU deaths, lower family satisfaction.
  • Prognostic uncertainty: Clinicians overestimate survival (systematic bias). Tools: PPS, FAST, NECPAL, surprise question ("Would I be surprised if this patient died in 12 months?").
  • Live discharges: Not failure — reflects prognostic uncertainty. Requires re-certification if re-enrolled.
  • Concurrent care demonstration: Testing curative + hospice simultaneously (CMS pilot) — may shift enrollment earlier.

Quality Metrics (Hospice Compare)

  • Hospice visits in last 3 days of life (RN, SW, chaplain).
  • Care consistency (same nurse).
  • Family caregiver experience (CAHPS Hospice Survey).
  • Pain/symptom management timeliness.

The 74-day average masks a bimodal reality: many patients receive days, not months, of benefit. Earlier goals-of-care conversations and prognostic transparency are essential to maximize hospice value.

Hospice - Related Articles

Health Sciences © https://www.222health.com

Primary DiagnosisMedian LOSMean LOSNotes
Cancer18–22 days45–55 daysPredictable trajectory; earlier referral common
Heart Disease (CHF, CAD)14–18 days50–65 daysUnpredictable exacerbations; live discharges higher
Dementia / Alzheimer's30–45 days90–110 daysSlow decline; FAST stage 7c+ eligibility
COPD / Lung Disease18–25 days60–80 daysExacerbation-driven
Stroke / CVA20–30 days65–85 daysVariable trajectory
Renal Failure12–18 days40–55 daysDialysis discontinuation common trigger